$CUR Company News This tiny biotech company takes the

New Post Public Reply Private Reply Replies (0) Message Board

Jan 8, 2015 at 11:49 AM

$CUR Company News

This tiny biotech company takes the real ice bucket challenge 9:14 a.m. Sept. 2, 2014 - Michael Brush
Neuralstem gets FDA okay for depression study 9:28 a.m. Oct. 17, 2012 - MarketWatch.com
Stocks to watch Monday: LDK, OfficeMax 4:27 p.m. Sept. 14, 2012 - William Spain
Friday’s biggest gaining and declining stocks 4:11 p.m. Sept. 14, 2012 - MarketWatch
Hot stocks to watch 6:14 a.m. Sept. 14, 2012 - MarketWatch.com
Stocks to watch Friday: Werner, Libbey, Delphi 6:07 a.m. Sept. 14, 2012 - MarketWatch
Canada hot stocks: Scotiabank, Great Panther 2:29 p.m. Aug. 30, 2011 - MarketWatch
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Drug stocks mixed after Fed statement 1:02 p.m. June 22, 2011 - Val Brickates Kennedy
Drug stocks gain while Nanosphere sinks 1:12 p.m. June 21, 2011 - Val Brickates Kennedy
Neuralstem soars on FDA move 2:00 p.m. Feb. 9, 2011 - Val Brickates Kennedy
Neuralstem, Impax in drug-sector spotlight 3:22 p.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem climbs as drug indexes hug flat line 10:02 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem soars on FDA nod 9:16 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Before the Close Report from the MarketWatch Radio Network 1:31 p.m. March 9, 2009 - Andrew O'Day
Geron's study OK signals progress for company, stem cell peers 1:13 p.m. Jan. 23, 2009 - MarketWatch.com
2007 could emerge as a pivotal year for stem-cell investing 5:43 p.m. Dec. 12, 2007 - Scott Austin
Palatin plunges on drug setback; Atherogenics continues rally 12:42 p.m. Aug. 30, 2007 - Val Brickates Kennedy
Neuralstem teams up with U Mich. for ALS research 8:26 a.m. Aug. 30, 2007 - Val Brickates Kennedy
Stem cell industry trying to see silver lining in funding fight 11:36 a.m. April 13, 2007 - Greg Presto

15 Biotech Names For 2015 2:37 p.m. Jan. 5, 2015 - Seeking Alpha
First Week Of August 21st Options Trading For Neuralstem (CUR) 11:32 a.m. Jan. 2, 2015 - TheStreet.com
Neuralstem (CUR) Stock Rises Today as Brainstorm Cell Therapeutics Soars 11:02 a.m. Jan. 2, 2015 - TheStreet.com
One Reason Neuralstem (CUR) Stock is Rising Today 12:42 p.m. Dec. 31, 2014 - TheStreet.com
Brainstorm Cell up on clinical trial results 10:25 a.m. Dec. 31, 2014 - Seeking Alpha
InVivo Therapeutics 4:56 p.m. Nov. 12, 2014 - Seeking Alpha
10-Q: NEURALSTEM, INC. 6:37 a.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cytokinetics ALS drug impacts disease progression in Phase 2b trial 9:57 a.m. Oct. 20, 2014 - Seeking Alpha
Genervon ALS drug shows encouraging results 7:27 a.m. Oct. 20, 2014 - Seeking Alpha
InVivo, Neuralstem Treat Spinal Cord Injury Patients 12:53 p.m. Oct. 16, 2014 - Seeking Alpha
Brainstorm CEO Offers Investors a Frank Outlook for ALS Therapy 7:30 a.m. Oct. 16, 2014 - TheStreet.com
First patient dosed in spinal cord injury stem cell trial 9:32 a.m. Oct. 10, 2014 - Seeking Alpha
Investigator presents NSI-566 follow up data 11:52 a.m. Sept. 22, 2014 - Seeking Alpha
Asterias cleared for stem cell trial in spinal cord injury 6:52 a.m. Aug. 27, 2014 - Seeking Alpha
Why Neuralstem Has Plenty Of Upside In The Short Term 7:29 a.m. Aug. 26, 2014 - Seeking Alpha
StemCells, Inc: Short-Term Noise Creates Another Buying Opportunity 7:14 a.m. Aug. 15, 2014 - Seeking Alpha
10-Q: NEURALSTEM, INC. 5:24 a.m. Aug. 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Researchers Fret as Social Media Lift Drug-Trial Veil 9:30 p.m. July 29, 2014 - The Wall Street Journal Interactive Edition
Second site begins enrolling patients in BrainStorm ALS trial 10:05 a.m. July 15, 2014 - Seeking Alpha
Behind The Promotion Of Northwest Bio 8:35 a.m. July 7, 2014 - Seeking Alpha

Neuralstem To Present At Biotech Showcase 2015 9:03 a.m. Jan. 6, 2015 - PR Newswire - PRF
Neuralstem Announces Publication Of Long Term Cell Survival From Phase I NSI-566 ALS Study In The Journal "Annals Of Clinical And Translational Neurology" 9:00 a.m. Nov. 10, 2014 - PR Newswire - PRF
Neuralstem Reports Third Quarter Financial Results And Provides Business And Clinical Update 9:00 a.m. Nov. 7, 2014 - PR Newswire - PRF
First Patient Treated In Neuralstem Phase I Spinal Cord Injury Stem Cell Trial Through The UC San Diego Sanford Stem Cell Clinical Center 8:15 a.m. Oct. 9, 2014 - PR Newswire - PRF
Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 8:15 a.m. Sept. 22, 2014 - PR Newswire - PRF
Neuralstem President And CEO To Present At The 2014 Rodman & Renshaw Annual Global Investment Conference 8:15 a.m. Sept. 5, 2014 - PR Newswire - PRF
Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update 7:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
Final Patient Treated In Neuralstem Phase II ALS Stem Cell Trial 8:15 a.m. Aug. 4, 2014 - PR Newswire - PRF
Morning Briefing on Biotech Stocks -- Research on Dynavax Technologies, Synergy Pharma, Infinity Pharma, and Neuralstem 6:00 a.m. July 2, 2014 - PR Newswire - PRF
Neuralstem's NSI-189 Novel Neurogenic Compound Shows Significant Effect In Major Depressive Disorder 8:15 a.m. June 25, 2014 - PR Newswire - PRF
Neuralstem NSI-189 Select Data To Be Presented At Neuropsychopharmacology Congress 8:15 a.m. June 19, 2014 - PR Newswire - PRF
Neuralstem Final Phase I Depression Data Presented At The American Society Of Clinical Psychopharmacology Annual Meeting 8:15 a.m. June 18, 2014 - PR Newswire - PRF
Neuralstem, Inc. - "The FDA is Not the Enemy" 8:26 a.m. June 9, 2014 - ACCESSWIRE
Morning Briefing on Top Gainers -- Research on GTx Inc., Iridium Communications, Neuralstem, and Idera Pharma 5:50 a.m. May 29, 2014 - PR Newswire - PRF
Neuralstem, Inc. - "Most men would rather deny a hard truth than face it" 10:36 a.m. May 28, 2014 - ACCESSWIRE
Neuralstem Depression Trial Data to Be Presented at The American Society of Clinical Psychopharmacology Annual Meeting 8:28 a.m. May 23, 2014 - PR Newswire - PRF
Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update 8:15 a.m. May 12, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on Assured Guaranty, Ampio Pharma, Neuralstem, and Kennedy-Wilson Holdings 12:34 p.m. May 9, 2014 - PR Newswire - PRF
Neuralstem Appoints Sandford Drexel Smith, Former Genzyme Executive Vice President, To Board Of Directors 8:15 a.m. May 8, 2014 - PR Newswire - PRF
Neuralstem Spinal Cord Injury Stem Cell Trial Approved To Commence At University Of California, San Diego 8:15 a.m. April 16, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Oil Markets Shift Focus: Pipelines Trump Drilling

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

QuickFi Nabs Top Finovate Award for Fourth Time

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

2026 Buy-Side Index Reveals State Market Variance

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Jari Spirits Set to Shake Up U.S. Market After Big Wins

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Melissa Rivers Brings Her Wit Back to Emmys Carpet

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Intus Bio Secures $2.7M for Colorectal Cancer Test

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Americas Cardroom's Poker Series Hits $7.2M Haul

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

DCM Services Teams with AKUVO to Boost Estate Recoveries

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Lick the Plate Hits 2,000 Shows with Clown Band

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

NYSE Reflects on 9/11: Honoring Lives and Legacy

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...